Takayuki Mizutani
Direktor/Vorstandsmitglied bei Theoria Science KK
Ursprung des Netzwerks ersten Grades von Takayuki Mizutani
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Theoria Science KK
 Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Takayuki Mizutani
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
UTokyo Innovation Platform Co.,Ltd.
 UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | Investment Managers | Private Equity Investor |
Statistik
International
| Japan | 2 |
Sektoral
| Finance | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Director of Finance/CFO | 1 |
| Private Equity Investor | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Akihiko Asami | 2 |
| Takahiro Ochiya | 1 |
- Börse
- Insiders
- Takayuki Mizutani
- Unternehmensverbindungen
